Neopeutics Overview
- Founded
-
2009
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Neopeutics General Information
Description
Developer of targeted and cost-effective tools designed for enhanced drug discovery. The company's range of offerings includes a screening technology package, bioinformatics software tools, candidate development and commercialization technology, enabling biotechnology and pharmaceutical firms to improve the affordability and efficacy of the drug discovery process.
Contact Information
Website
www.neopeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Other Healthcare Services
Primary Office
- 400 Oyster Point Boulevard
- Suite 112
- South San Francisco, CA 94080
- United States
+1 (650) 000-0000
Neopeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | Completed | Startup |
Neopeutics Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Anton Espira Ph.D | Co-Founder & Chief Operating Officer | ||
| Harlizawati Jahari Ph.D | Co-Founder, Executive Director & Chief Executive Officer | ||
| Nevan Krogan Ph.D | Co-Founder |
Neopeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Neopeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| QB3 | Accelerator/Incubator | 000 0000 | 000000 0 |